Today: 7 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Microsoft Stock (MSFT) News, Forecasts & Analysis for Dec. 14, 2025: AI Mega-Investments, Azure Momentum, and Wall Street’s $630–$650 Targets

Microsoft Stock (MSFT) News, Forecasts & Analysis for Dec. 14, 2025: AI Mega-Investments, Azure Momentum, and Wall Street’s $630–$650 Targets

Microsoft shares last traded near $478.53 as of Dec. 14, 2025, after announcing $23 billion in new AI infrastructure spending, including $17.5 billion for India and $5.4 billion for Canada. The stock remains volatile, with a 52-week range from $344.79 to $555.45. Investors are weighing rising capital expenditures against strong Azure and Copilot demand.
14 December 2025
···
Oracle Stock (ORCL) Outlook on Dec. 14, 2025: AI Spending Shock, OpenAI Data Center Delays, and Wall Street Forecasts

Oracle Stock (ORCL) Outlook on Dec. 14, 2025: AI Spending Shock, OpenAI Data Center Delays, and Wall Street Forecasts

Oracle shares closed at $189.97, down 4.56% after fiscal Q2 results beat earnings estimates but raised concerns over AI infrastructure spending and slower revenue conversion. Analyst consensus remains “Moderate Buy,” with average 12-month price targets near $300. Oracle’s Q3 guidance missed expectations, projecting adjusted EPS of $1.64–$1.68 and revenue growth of 16%–18%.
14 December 2025
··
Apple Stock (AAPL) News and Forecasts for December 14, 2025: iPhone 17 Momentum, 2026 AI Catalysts, and Wall Street Price Targets

Apple Stock (AAPL) News and Forecasts for December 14, 2025: iPhone 17 Momentum, 2026 AI Catalysts, and Wall Street Price Targets

Apple stock closed Friday at $278.28, up 0.1%, sitting near its 52-week high. Investors are focused on strong iPhone 17 demand, especially in China, and speculation about Apple’s AI plans for 2026, including a more advanced Siri. Regulatory and legal pressures persist. Wall Street analysts have raised price targets on expectations of continued growth.
14 December 2025
Broadcom (AVGO) Stock Outlook on Dec. 14, 2025: AI Chip Boom, Margin Pressure, and Wall Street Price Targets

Broadcom (AVGO) Stock Outlook on Dec. 14, 2025: AI Chip Boom, Margin Pressure, and Wall Street Price Targets

Broadcom shares fell 11% to $359.93 after reporting strong Q4 results and raising Q1 revenue guidance, as investors reacted to margin pressure from increased AI-related sales. Management projected $8.2 billion in AI semiconductor revenue for the current quarter and disclosed a $73 billion AI backlog. The selloff dragged down tech indexes despite all tracked analysts maintaining “buy” ratings and several firms raising price targets.
14 December 2025
·
NVIDIA Stock (NVDA) News Today: China H200 Export Shift, AI Spending Jitters, and Wall Street Forecasts (Dec. 14, 2025)

NVIDIA Stock (NVDA) News Today: China H200 Export Shift, AI Spending Jitters, and Wall Street Forecasts (Dec. 14, 2025)

Nvidia shares closed Friday at $175.02 after a volatile week for AI chip stocks. The U.S. will allow exports of Nvidia’s H200 AI processors to China with a 25% import fee, but not its newest Blackwell or Rubin chips. Nvidia is considering increasing H200 production as Chinese demand exceeds supply. The Commerce Department is finalizing export terms.
14 December 2025
·
Tesla Stock News and Forecasts for Dec. 14, 2025: Robotaxi Countdown, Sales Signals, and Wall Street Targets for TSLA

Tesla Stock News and Forecasts for Dec. 14, 2025: Robotaxi Countdown, Sales Signals, and Wall Street Targets for TSLA

Tesla closed Friday at $458.96, rising 2.7% amid renewed focus on autonomy and robotics. Elon Musk said Tesla may remove safety monitors from its Austin robotaxi fleet within three weeks. U.S. November sales dropped nearly 23% year over year to about 39,800 vehicles, the lowest since early 2022. A recent analyst downgrade has fueled debate over the company’s valuation.
14 December 2025
···
Nu Holdings (NU) Stock Update: Brazil Banking-License Push, Colombia’s 4M Milestone, and Key Catalysts for the Week Ahead (Updated Dec. 12, 2025)

Nu Holdings (NU) Stock Update: Brazil Banking-License Push, Colombia’s 4M Milestone, and Key Catalysts for the Week Ahead (Updated Dec. 12, 2025)

Nu Holdings (NYSE: NU) closed Dec. 12, 2025, at about $16.90, recovering after a 5.38% drop on Dec. 5 and ending the week up 1.2%. The company disclosed plans to seek a full banking license in Brazil by 2026, citing regulatory changes. Bloomberg reported Nu may consider acquiring a small Brazilian bank, with Banco Digimais named as a possible target. Nubank serves over 110 million customers in Brazil.
14 December 2025
··
Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Destiny Tech100 (DXYZ) surged 38% in five sessions, closing Dec. 12 at $37.96 on heavy volume, as speculation over a potential SpaceX IPO drew investor interest. The closed-end fund, which holds late-stage private tech firms, traded far above its net asset value. Friday’s volume hit 7.58 million shares, with pre-market activity also spiking. DXYZ’s price often moves on sentiment rather than underlying portfolio value.
14 December 2025
··
Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Milestone Pharmaceuticals said late Friday the FDA approved CARDAMYST (etripamil) as the first self-administered nasal spray for PSVT. MIST shares closed down 18.3% at $2.41 after volatile trading and heavy volume, but rebounded modestly after hours. CARDAMYST is expected in pharmacies in Q1 2026. In a Phase 3 trial, 64% of patients converted to normal rhythm within 30 minutes, compared to 31% on placebo.
14 December 2025
··
MercadoLibre Stock (NASDAQ: MELI) Weekly Update and Week-Ahead Outlook: Humanoid Robots Deal, $750M Notes, and Key Levels to Watch (Updated Dec. 12, 2025)

MercadoLibre Stock (NASDAQ: MELI) Weekly Update and Week-Ahead Outlook: Humanoid Robots Deal, $750M Notes, and Key Levels to Watch (Updated Dec. 12, 2025)

MercadoLibre closed at $2,015.89 on Dec. 12 after a volatile week marked by a 5% drop Wednesday and a rebound. The company announced a pilot with Agility Robotics to deploy humanoid robots in its Texas warehouse, with possible expansion to Latin America. MercadoLibre also completed a $750 million bond offering, its first since reaching investment grade.
14 December 2025
··
Medical Properties Trust (MPW) Stock: This Week’s Slide, Tenant Headlines, Dividend Update, and What to Watch Next Week (Updated Dec. 12, 2025)

Medical Properties Trust (MPW) Stock: This Week’s Slide, Tenant Headlines, Dividend Update, and What to Watch Next Week (Updated Dec. 12, 2025)

Medical Properties Trust (NYSE: MPW) closed the week at about $5.10, down nearly 7% after a sharp 5.35% drop Thursday. The decline followed renewed scrutiny of tenant Prospect Medical’s finances and news that MPW will pay $7.65 million in a Waterbury hospital tax settlement. No major company press releases were issued during the week.
14 December 2025
·
NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy closed at $81.65 on Dec. 12, down 1.8% from the prior week. Shares fell sharply early in the week before rebounding, following news of new Google Cloud and Meta energy agreements. The company raised its 2025–2026 earnings guidance and analysts issued fresh price targets.
14 December 2025
····
Realty Income (NYSE: O) Stock This Week: Dividend Hike, $800M Las Vegas Deal, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Realty Income (NYSE: O) Stock This Week: Dividend Hike, $800M Las Vegas Deal, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Realty Income shares closed at $57.72 on Dec. 12, down 1.3% for the week despite a new monthly dividend increase and an $800 million preferred equity investment in CityCenter Las Vegas. The stock slid early, then recovered as markets reacted to the Federal Reserve’s rate cut to 3.5%–3.75%. The new dividend is $0.2700 per share, payable Jan. 15.
14 December 2025
··
DoorDash Stock Forecast (DASH): News, Catalysts, and Week-Ahead Outlook After Friday’s $227.49 Close (Updated Dec. 12, 2025)

DoorDash Stock Forecast (DASH): News, Catalysts, and Week-Ahead Outlook After Friday’s $227.49 Close (Updated Dec. 12, 2025)

DoorDash shares closed Friday at $227.49, up 1.32% for the day and capping a volatile week marked by a sharp midweek drop after Amazon expanded same-day grocery delivery to over 2,300 U.S. cities. The stock fell 4.2% Wednesday before rebounding, finishing the week with a 7% trading range. DoorDash is up about 35% year-to-date but remains 20% below its October high.
13 December 2025
·
Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Nike shares closed Friday at $67.47, down 0.40% on the day but up 6.2% from Monday’s close after a volatile week. The stock rebounded midweek as the Federal Reserve cut rates by 25 basis points. Nike also named Venkatesh Alagirisamy as its first chief operating officer, restructuring senior leadership ahead of its Q2 earnings report on Dec. 18.
13 December 2025
···
1 … 576 577 578 579 580 … 690
Go toTop